Selenate supplementation mitigated hyperlipidemia (Fig. 5A,B) and slightly decreased the levels of insulin and HbA1c induced by HFD (Fig. 5C,D), suggesting a protective role of selenate on HFD-induced dysregulation of lipid metabolism. Here, INS is linked to hyperlipidemia.